Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study

MLA

Chiung-Ling Liao, et al. “Progesterone Receptor Does Not Improve the Performance and Test Effectiveness of the Conventional 3-Marker Panel, Consisting of Estrogen Receptor, Vimentin and Carcinoembryonic Antigen in Distinguishing between Primary Endocervical and Endometrial Adenocarcinomas in a Tissue Microarray Extension Study.” Journal of Translational Medicine, vol. 7, Jan. 2009, pp. 1–9. EBSCOhost, https://doi.org/10.1186/1479-5876-7-37.

APA

Chiung-Ling Liao, Ming-Yung Lee, Yeu-Sheng Tyan, Lai-Fong Kok, Tina S. Wu, Chiew-Loon Koo, Po-Hui Wang, Kuan-Chong Chao, & Chih-Ping Han. (2009). Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study. Journal of Translational Medicine, 7, 1–9. https://doi.org/10.1186/1479-5876-7-37

Chicago

Chiung-Ling Liao, Ming-Yung Lee, Yeu-Sheng Tyan, Lai-Fong Kok, Tina S. Wu, Chiew-Loon Koo, Po-Hui Wang, Kuan-Chong Chao, and Chih-Ping Han. 2009. “Progesterone Receptor Does Not Improve the Performance and Test Effectiveness of the Conventional 3-Marker Panel, Consisting of Estrogen Receptor, Vimentin and Carcinoembryonic Antigen in Distinguishing between Primary Endocervical and Endometrial Adenocarcinomas in a Tissue Microarray Extension Study.” Journal of Translational Medicine 7 (January): 1–9. doi:10.1186/1479-5876-7-37.